The Obesity Action Coalition (OAC) is a U.S.-based nonprofit organization focused on elevating and empowering people affected by obesity through education, advocacy, and support. Its work spans patient education resources, awareness campaigns aimed at reducing weight stigma, and advocacy on policy issues affecting obesity treatment access, including insurance coverage. It's an example of the kind of organization described in our guide on the role of patient advocacy organizations in obesity treatment policy.
Obesity Action Coalition (OAC)
A U.S. nonprofit patient advocacy organization focused on obesity education, awareness, and access to treatment.
Updated Sep 26, 2026
Was this helpful?
Revision history
Last updated Β· 2 revisions recorded.
Show what changed
- v2
Body revised
- v1
Existing article recorded at the start of version history
Improve this page
Community notes
Share helpful experiences and questions. Notes are reviewed before publication and do not replace medical advice.
Loading notesβ¦
New submissions are currently paused. Existing approved notes remain available.
Related guides
- How to contact your lawmakers about GLP-1 coverage: a step-by-step guide β Congressional staff say individualized contact from constituents sways undecided lawmakers, but most messages leave out what staff find useful. This guide shows how to find your federal and state legislators, match your ask to the right level of government (TROA, the Medicare fix, state mandates, Medicaid), pick a channel, tell your story, and follow up, with a call script and email template.
- FDA's proposal to keep compounded GLP-1s off the 503B bulks list β and how to comment β In May 2026 the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list, a decision that affects how compounded GLP-1s can be made. The public comment period closed July 30, 2026, and as of late September 2026 the FDA has not published a final determination. This guide explains the proposal, why it matters for access, and what you can still do.
- Obesity Action Coalition (official site) β The official site of the Obesity Action Coalition, a national patient advocacy nonprofit: education, community support and advocacy resources for people affected by obesity.
- The Obesity Society β The leading U.S.-based professional society for obesity science and treatment. Its position statements, journal and annual ObesityWeek meeting are useful sources for patients and advocates.
- The Treat and Reduce Obesity Act (H.R. 4231 / S. 1973): what it is and why it matters β TROA is the main federal bill aimed at ending Medicare's exclusion of obesity medications. It was first introduced in 2013 and has been reintroduced with bipartisan support in later Congresses, but it hasn't passed. This guide explains what it would change.
- Escalation paths beyond your insurer: commissioners, ombudsmen, and external review β When your insurer's internal appeals are exhausted, you still have options: independent external review, state regulators, the Department of Labor for self-funded employer plans, and state consumer assistance programs or health insurance advocates. Who does what, and when each applies.